Levosalbutamol Dosing for Reversible Bronchospasm
For acute asthma or COPD exacerbations, use levosalbutamol (levalbuterol) 1.25-2.5 mg via nebulizer every 20 minutes for 3 doses, then 1.25-5 mg every 1-4 hours as needed in adults; for children, use 0.075 mg/kg (minimum 1.25 mg) every 20 minutes for 3 doses, then 0.075-0.15 mg/kg up to 5 mg every 1-4 hours as needed. 1
For maintenance therapy via MDI, the standard dose is 2 inhalations (90 mcg total) every 4-6 hours for both adults and children ≥4 years, though 1 inhalation every 4 hours may suffice in some patients. 2
Acute Exacerbations (Emergency/Hospital Setting)
Nebulized Solution Dosing
Adults:
- Initial treatment: 1.25-2.5 mg every 20 minutes for 3 doses
- Maintenance: 1.25-5 mg every 1-4 hours as needed
- Note: Levosalbutamol provides comparable efficacy at one-half the mg dose of racemic albuterol 1
Children (≥4 years):
- Initial treatment: 0.075 mg/kg (minimum 1.25 mg) every 20 minutes for 3 doses
- Maintenance: 0.075-0.15 mg/kg up to 5 mg every 1-4 hours as needed 1
Children (2-5 years):
- Start with 0.31 mg three times daily for mild-moderate asthma
- May increase to 0.63 mg if needed for more severe disease 3
MDI Dosing (Acute Setting)
- Follow the same puff frequency as racemic albuterol: 4-8 puffs every 20 minutes for 3 doses, then every 1-4 hours as needed 1
Maintenance Therapy (Outpatient Setting)
MDI (Xopenex HFA)
Adults and children ≥4 years:
- Standard dose: 2 inhalations (90 mcg) every 4-6 hours
- Some patients may respond to 1 inhalation every 4 hours 2
Important caveat: More frequent administration or larger numbers of inhalations are not routinely recommended. If a previously effective regimen fails, this signals asthma destabilization requiring reevaluation and consideration of anti-inflammatory therapy (inhaled corticosteroids). 2
Key Clinical Considerations
Dosing Equivalence
Levosalbutamol at half the mg dose of racemic albuterol provides comparable efficacy and safety because it contains only the active R-isomer without the inactive S-isomer. 1 This means 1.25 mg levosalbutamol ≈ 2.5 mg racemic albuterol.
Age-Specific Starting Doses
- Children 4-11 years with mild-moderate persistent asthma: Start with 0.31 mg as the initial dose 4
- Children with severe asthma: May benefit from higher doses (0.63 mg), as a dose-response relationship exists 4
- Children 2-5 years: Use 0.31 mg without regard to weight; 0.63 mg may be used but shows increased heart rate effects 3
Safety Profile Advantages
Levosalbutamol 0.31 mg is the only bronchodilator dose that does not differ from placebo for changes in heart rate, QTc interval, and glucose levels. 4 This makes it particularly advantageous in patients with cardiovascular concerns or those requiring frequent dosing.
Continuous Nebulization
The guidelines note that levosalbutamol has not been evaluated by continuous nebulization, unlike racemic albuterol which can be given at 10-15 mg/hour continuously in severe exacerbations. 1 If continuous nebulization is needed, racemic albuterol remains the evidence-based choice.
Clinical Outcomes
Research shows levosalbutamol every 6-8 hours requires significantly fewer total nebulizations compared to racemic albuterol every 1-4 hours (median 10 vs 12 treatments, p=0.031), without increased need for rescue treatments. 5 However, one study found longer hospital stays with levosalbutamol, though this may reflect institutional practices rather than drug efficacy. 6
Common Pitfall
Do not use levosalbutamol as monotherapy for persistent asthma. Current guidelines emphasize that all patients with persistent asthma should receive ICS-containing medication and should not be treated with SABA alone. 7, 8 Levosalbutamol is for quick relief and acute exacerbations, not as sole controller therapy.
Device Maintenance
For MDI use, the actuator must be washed and dried thoroughly at least once weekly to prevent medication buildup and blockage that can stop drug delivery. 2